Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
11.73
+0.17 (1.47%)
At close: Aug 21, 2026
SHA:688203 Revenue
Zhejiang Hisun Biomaterials Co.Ltd. had revenue of 267.56M CNY in the quarter ending March 31, 2026, with 30.28% growth. This brings the company's revenue in the last twelve months to 913.88M, up 6.44% year-over-year. In the year 2025, Zhejiang Hisun Biomaterials Co.Ltd. had annual revenue of 851.69M with 0.77% growth.
Revenue (ttm)
913.88M
Revenue Growth
+6.44%
P/S Ratio
2.58
Revenue / Employee
2.02M
Employees
453
Market Cap
2.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 851.69M | 6.50M | 0.77% |
| Dec 31, 2024 | 845.19M | 91.87M | 12.20% |
| Dec 31, 2023 | 753.32M | 147.88M | 24.43% |
| Dec 31, 2022 | 605.43M | 20.43M | 3.49% |
| Dec 31, 2021 | 585.01M | 322.34M | 122.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ningxia Yinglite Chemicals | 1.65B |
| Hunan Hengguang Technology | 1.54B |
| BSM Chemical | 1.45B |
| Gpro Titanium Industry | 1.32B |
| Zhe Jiang Dayang Biotech Group | 1.07B |
| Yangzhou Chenhua New Material | 965.93M |
| Yangfan New Materials (Zhejiang) | 890.72M |
| Weifang Yaxing Chemical | 829.18M |